Join
Live feed
·
INSIDERFilingvia Quantisnow
Royalty Pharma plc logo

EVP, Research & Investments Urist Marshall sold $508,454 worth of Class A Ordinary Shares (9,099 units at $55.88) as part of a pre-agreed trading plan, closing all direct ownership in the company (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
RPRX· Royalty Pharma plc
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track RPRX (Royalty Pharma plc) and more on Quantisnow.